Testing Content Delivery Models for MomConnect
Launched by IDINSIGHT · Aug 16, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to improve the MomConnect program, which sends health messages to pregnant women through WhatsApp. MomConnect helps mothers by providing important information about immunization, breastfeeding, and other health topics during pregnancy and early childhood. The trial aims to see if different ways of delivering these messages can engage mothers more effectively, leading to better knowledge and healthier behaviors for themselves and their babies.
To participate in this study, you need to be a pregnant woman over 18 years old who is signing up for MomConnect while being between 16 and 30 weeks pregnant. If you join, you can expect to receive various health messages tailored to your needs, which could help you learn more about important health practices. This trial is currently looking for participants, so if you meet the criteria, you may have the opportunity to contribute to improving maternal health support for mothers everywhere!
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Pregnant women above the age of 18 signing up for MomConnect when being between 16-30 weeks pregnant
- Exclusion Criteria:
- • All others
About Idinsight
Idinsight is a leading organization dedicated to enhancing the effectiveness of development programs through rigorous data-driven insights. Specializing in impact evaluation, research, and strategic consulting, Idinsight collaborates with governments, nonprofits, and businesses to inform decision-making and optimize resource allocation. Their expertise in designing and implementing robust clinical trials and evaluations ensures that interventions are not only evidence-based but also tailored to meet the unique needs of diverse populations. With a commitment to transparency and innovation, Idinsight leverages advanced methodologies and technologies to drive sustainable improvement in health and social outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cape Town, , South Africa
Cape Town, , South Africa
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials